Equity Capital Markets

Company · CIK 1853921

Scribe Therapeutics, Inc.

CIK1853921 (SEC EDGAR)
Industry (SIC)2836 — Biological Products, (No Diagnostic Substances)
Incorporated inDE
Business addressCA
ListedSCTX (Nasdaq)
First annual or quarterly report2026-09-02

Offerings

1 registration
RegistrationLabel and statusFirst filedLast eventFilings
333-297246
IPOFinal prospectus
 2026-07-022026-07-275

Filings

6
FiledFilingRegistrationAccession
2026-07-27424B4Final prospectus 333-2972460001193125-26-316503
2026-07-23EFFECTDeclared effective 333-2972469999999995-26-002417
2026-07-20S-1/AAmendment 333-2972460001193125-26-308330
2026-07-10S-1/AAmendment 333-2972460001193125-26-300994
2026-07-02S-1Registration filed 333-2972460001193125-26-294804
2026-01-09DRSDraft made public 377-089280001193125-26-009106

All filings of this company · CSV